These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 34551694)

  • 1. Antimycotic Drugs and their Mechanisms of Resistance to
    Dahiya S; Sharma N; Punia A; Choudhary P; Gulia P; Parmar VS; Chhillar AK
    Curr Drug Targets; 2022; 23(2):116-125. PubMed ID: 34551694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Echinocandin antifungal drugs in fungal infections: a comparison.
    Chen SC; Slavin MA; Sorrell TC
    Drugs; 2011 Jan; 71(1):11-41. PubMed ID: 21175238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of antifungal resistance development on the virulence of Candida species.
    Bohner F; Papp C; Gácser A
    FEMS Yeast Res; 2022 Apr; 22(1):. PubMed ID: 35325128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Review on Molecular Mechanisms of Antifungal Resistance in
    Lotfali E; Fattahi A; Sayyahfar S; Ghasemi R; Rabiei MM; Fathi M; Vakili K; Deravi N; Soheili A; Toreyhi H; Shirvani F
    Microb Drug Resist; 2021 Oct; 27(10):1371-1388. PubMed ID: 33956513
    [No Abstract]   [Full Text] [Related]  

  • 7. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).
    Pfaller MA; Messer SA; Moet GJ; Jones RN; Castanheira M
    Int J Antimicrob Agents; 2011 Jul; 38(1):65-9. PubMed ID: 21514797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Triazole Evolution of Candida parapsilosis Results in Cross-Resistance to Other Antifungal Drugs, Influences Stress Responses, and Alters Virulence in an Antifungal Drug-Dependent Manner.
    Papp C; Bohner F; Kocsis K; Varga M; Szekeres A; Bodai L; Willis JR; Gabaldón T; Tóth R; Nosanchuk JD; Vágvölgyi C; Gácser A
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33115837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Approaches for Combating
    Punia A; Choudhary P; Sharma N; Dahiya S; Gulia P; Chhillar AK
    Curr Drug Targets; 2022; 23(16):1465-1488. PubMed ID: 35748549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
    Fera MT; La Camera E; De Sarro A
    Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance of Candida to azoles and echinocandins worldwide.
    Pristov KE; Ghannoum MA
    Clin Microbiol Infect; 2019 Jul; 25(7):792-798. PubMed ID: 30965100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Striking Back against Fungal Infections: The Utilization of Nanosystems for Antifungal Strategies.
    Du W; Gao Y; Liu L; Sai S; Ding C
    Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antifungals.
    Campoy S; Adrio JL
    Biochem Pharmacol; 2017 Jun; 133():86-96. PubMed ID: 27884742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent approaches to antifungal therapy for invasive mycoses.
    Mathew BP; Nath M
    ChemMedChem; 2009 Mar; 4(3):310-23. PubMed ID: 19170067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Echinocandins: The Expanding Antifungal Armamentarium.
    Aguilar-Zapata D; Petraitiene R; Petraitis V
    Clin Infect Dis; 2015 Dec; 61 Suppl 6():S604-11. PubMed ID: 26567277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A chemical screen identifies structurally diverse metal chelators with activity against the fungal pathogen
    Fallah S; Duncan D; Reichl KD; Smith MJ; Wang W; Porco JA; Brown LE; Whitesell L; Robbins N; Cowen LE
    Microbiol Spectr; 2024 Apr; 12(4):e0409523. PubMed ID: 38376363
    [No Abstract]   [Full Text] [Related]  

  • 17. Echinocandin Resistance in Candida.
    Perlin DS
    Clin Infect Dis; 2015 Dec; 61 Suppl 6(Suppl 6):S612-7. PubMed ID: 26567278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candida bloodstream infections: comparison of species distributions and antifungal resistance patterns in community-onset and nosocomial isolates in the SENTRY Antimicrobial Surveillance Program, 2008-2009.
    Pfaller MA; Moet GJ; Messer SA; Jones RN; Castanheira M
    Antimicrob Agents Chemother; 2011 Feb; 55(2):561-6. PubMed ID: 21115790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New antifungal agents.
    Gupta AK; Tomas E
    Dermatol Clin; 2003 Jul; 21(3):565-76. PubMed ID: 12956208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New and Promising Chemotherapeutics for Emerging Infections Involving Drug-resistant Non-albicans Candida Species.
    Silva LN; de Mello TP; de Souza Ramos L; Branquinha MH; Dos Santos ALS
    Curr Top Med Chem; 2019; 19(28):2527-2553. PubMed ID: 31654512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.